Subfoveal choroidal neovascularisation - initial authority application form (PB072)

Use this form to apply for initial PBS-subsidised treatment with aflibercept, brolucizumab, faricimab or ranibizumab for subfoveal choroidal neovascularisation.

Page last updated: 1 June 2025.
QC 20701